Brilinta recalls
Brilinta products have been recalled 2 times, most recently on 2 Jun 2021. The recalling company is usually AstraZeneca Pharmaceuticals. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2017
Last 12 months0reported
Class I150% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 1 50%Class III 0 0%
Why brilinta is recalled
Companies
Product types
By year
All brilinta recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Brilinta ticagrelar tablets 60 mg recalled by Cardinal HealthBrilinta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS I | Brilinta (ticagrelor) tablets, 90 mg Professional Sample recalledBrilinta | AstraZeneca Pharmaceuticals | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.